Last quarter (Q ), Vivani Medical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Vivani Medical's net income was $-3.08M. See Vivani Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	$ 0.00	$ 0.00	$ 3.38M	$ 6.90M	$ 7.96M
Cost of Revenue	$ -130.00K	$ -130.00K	$ -500.00K	$ 2.15M	$ 4.89M	$ 5.12M
Gross Profit	$ 130.00K	$ 130.00K	$ 500.00K	$ 1.23M	$ 2.01M	$ 2.85M
Operating Expense	$ 9.27M	$ 9.06M	$ 13.17M	$ 31.82M	$ 36.63M	$ 31.46M
Operating Income	$ -9.14M	$ -8.93M	$ -12.67M	$ -30.60M	$ -34.63M	$ -28.61M
Net Non Operating Interest Income Expense	$ 4.00K	$ 12.00K	$ 16.00K	$ 362.00K	$ 86.00K	$ 93.00K
Other Income Expense	$ 55.00K	-	$ -2.23M	$ -3.36M	$ -555.00K	-
Pretax Income	$ -9.07M	$ -8.92M	$ -14.88M	$ -33.59M	$ -35.09M	$ -28.52M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -9.07M	$ -8.92M	$ -14.88M	$ -33.59M	$ -35.09M	$ -28.52M
Basic EPS	$ -0.38	$ -0.81	$ -0.72	$ -18.24	$ -33.84	$ -4.24
Diluted EPS	$ -0.38	$ -0.81	$ -0.72	$ -18.24	$ -33.84	$ -4.24
Basic Average Shares	$ 131.43M	$ 10.94M	$ 20.57M	$ 1.84M	$ 1.04M	$ 6.77M
Diluted Average Shares	$ 131.43M	$ 10.94M	$ 20.57M	$ 1.84M	$ 1.04M	$ 6.77M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	$ -15.28	-	$ -4.08
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 9.14M	$ 8.93M	$ 12.67M	$ 33.98M	$ 41.52M	$ 36.57M
Net Income From Continuing And Discontinued Operation	$ -9.07M	$ -8.92M	$ -14.88M	$ -33.59M	$ -35.09M	$ -28.52M
Normalized Income	$ -9.07M	$ -8.92M	$ -12.65M	$ -30.23M	$ -34.54M	$ -28.52M
Interest Expense	-	-	-	-	-	-
EBIT	$ -9.14M	$ -8.93M	$ -12.67M	$ -30.60M	$ -34.63M	$ -28.61M
EBITDA	$ -9.08M	$ -8.86M	$ -12.50M	$ -30.20M	$ -34.19M	$ -28.15M

Currency in USD

Vivani Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing